Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | PARP1 | P09874 | 1/20 | 0.62 |
| ▸ | CES2 | O00748 | 2/20 | 0.61 |
| ▸ | CES1 | P23141 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | AOC2 | O75106 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | GRM5 | P41594 | 1/20 | 0.53 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30046370 | 1.00 | HDAC1 (0.69) | HDAC1HDAC6KDM4EALDH1A1PARP1 | |
| SCHEMBL4238810 | 0.87 | KMT2A (0.67) | KDM4EALDH1A1MEN1KMT2AKCNK3 | |
| SCHEMBL77384 | 0.85 | ALDH1A1 (0.76) | HDAC6KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL29200437 | 0.83 | HDAC1 (0.50) | HDAC1HDAC6KDM4EALDH1A1PARP1 | |
| SCHEMBL30986828 | 0.82 | HDAC6 (1.00) | HDAC1HDAC6KDM4EPARP1CES2 | |
| SCHEMBL28885353 | 0.82 | HDAC6 (1.00) | HDAC1HDAC6KDM4EPARP1CES2 | |
| SCHEMBL29379935 | 0.82 | HDAC6 (1.00) | HDAC1HDAC6KDM4EPARP1CES2 | |
| SCHEMBL1904111 | 0.81 | ALDH1A1 (0.70) | KDM4EALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL14907946 | 0.80 | GAA (0.61) | HDAC1HDAC6KDM4EALDH1A1PARP1 | |
| SCHEMBL4910885 | 0.80 | HDAC1 (0.69) | HDAC1HDAC6KDM4EALDH1A1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977832-A | Benzoyl hydrazine antineoplastic compound and preparation method and application thereof | 江苏海洋大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119674192-A | PVDF-based organic-inorganic composite polymer solid electrolyte and preparation method and application thereof | 山东创鲁先进电池科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| US-20210005900-A1 | METHOD OF GENERATING ENERGY FROM A HYDRAZIDE CONTAINING ANODE FUEL, AND FUEL CELL | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-01-07 | — | — | US | claimed |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | claimed |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-13 | — | — | US | claimed |
| US-6337368-B1 | WATER INSOLUBLE CARRIERS WITH P-NITROBENZOIC ACID, AROMATIC AMINES, AMIDES, SULFONAMIDES AND HYDRAZIDES | KANEKA CORPORATION (JP) | 2002-01-08 | — | — | US | claimed |
| US-12338243-B2 | P2X7 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2025-06-24 | — | — | US | disclosed |
| CN-119977832-A | Benzoyl hydrazine antineoplastic compound and preparation method and application thereof | 江苏海洋大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119674192-A | PVDF-based organic-inorganic composite polymer solid electrolyte and preparation method and application thereof | 山东创鲁先进电池科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119504731-A | Naringenin derivative containing 1,3, 4-oxadiazole acylhydrazone structure and preparation method thereof | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2025-02-25 | — | — | CN | disclosed |
| US-20240300932-A1 | N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | GUIZHOU UNIVERSITY (CN) | 2024-09-12 | — | — | US | disclosed |
| CN-114466850-B | [1,2,4] Triazolo [1,5-C ] quinazolin-5-amine | 拜耳股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-5334726-A | Controlling weeds | ROHM AND HAAS COMPANY (US) | 1994-08-02 | — | — | US | disclosed |
| US-5120347-A | Pre and postemergence | ROHM AND HAAS COMPANY (US) | 1992-06-09 | — | — | US | disclosed |
| EP-0217748-B1 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1991-02-06 | — | — | EP | disclosed |
| US-4831013-A | BENZODIAZEPINE RECEPTOR ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| WO-1988002370-A1 | 2-SUBSTITUTED-E-FUSED-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINES PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | CIBA-GEIGY AG (CH) | 1988-04-07 | — | — | WO | disclosed |
| EP-0263071-A1 | 2-Substituted-e-fused-[1,2,4]-triazolo[1,5-c] pyrimidines, pharmaceutical compositions, and uses thereof | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| EP-0217748-A2 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1987-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300932-A1 | N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | PNMT, NNMT, PAH | HDAC1 356/4885HDAC6 535/4885KDM4E 1931/4885 |
| US-12338243-B2 | P2X7 modulators | P2RX7, P2RX4, P2RX1 | HDAC1 4244/4885HDAC6 3629/4885KDM4E 4071/4885 |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | GK, GMDS, UGCG | HDAC1 1777/4885HDAC6 965/4885KDM4E 2823/4885 |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | GK, GMDS, UGCG | HDAC1 1777/4885HDAC6 965/4885KDM4E 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.